‘It looks like this hypothesis will pan out’: Cullinan unveils data building case for autoimmune TCEs Read more →

Affibody gets izokibep ‘back on track’ while seeking ‘new home’ after drug’s Acelyrin rejection Read more →

Fierce Biotech Layoff Tracker 2026: Fulcrum cuts 85% of staff; Novartis trims research team Read more →